Amgen is facing a slowdown in uptake of its first-to-market KRAS inhibitor Lumakras as a second-line therapy for KRAS-mutated non-small cell lung ... low levels of PD-L1 expression (<1%), said ...

The researchers also discovered that "Galectin-1 can regulate gene expression ... fibroblast cell lines, investigating the effects of inhibiting both the protein and the KRAS gene, and observed ...

The researchers also discovered that "Galectin-1 can regulate gene expression ... fibroblast cell lines, investigating the effects of inhibiting both the protein and the KRAS gene, and observed ...